Arm Climbs 5% as Buyers Return After Sharp Pullback; Qualcomm Nudges Higher, Intel Sits Out the Rally

Chip buyers are stepping back into Arm Holdings (NASDAQ:ARM | ARM Price Prediction) stock. The rebound follows a steep drop and is running well ahead of the rest of the semiconductor group. Arm stock is at $321 in morning trading, up 5%. That gap with the sector marks the move as an Arm-specific bounce, with the chip designer’s royalty story doing the heavy lifting.

Meanwhile, Qualcomm (NASDAQ:QCOM) stock is at $196.48, up 1%, a far smaller gain than the one Arm stock is posting. Intel (NASDAQ:INTC) stock is at $127.72, up 0.3%, leaving the shares largely on the sidelines while Arm stock rallies.

Across the sector, the iShares Semiconductor ETF (NASDAQ:SOXX) is up 1%, a much smaller advance than Arm stock is managing. Large-cap technology is even quieter, with the Invesco QQQ Trust (NASDAQ:QQQ) up 0.43%. Both funds point to a calm backdrop for chips and tech, which leaves Arm stock as the standout mover in the group.

How Meta’s Muse Agent Re-Rated Arm

Earlier in the week, Arm stock and other semiconductor shares were re-rated on expectations that the Muse agent from Meta Platforms (NASDAQ:META) would shift a greater share of artificial intelligence (AI) inference toward the central processing unit (CPU) and away from graphics chips. That thesis lands directly on Arm, whose processor designs sit at the heart of CPUs built by its licensees. Arm stock then fell sharply, and the current bounce is a rebound after that decline.

As a design house, Arm licenses processor blueprints and related intellectual property to chipmakers, then collects royalties as those customers ship silicon and handle the manufacturing themselves, so each additional CPU a licensee ships adds to Arm’s royalty stream, which explains why a CPU-heavy inference story can move Arm stock so quickly. The same leverage cuts both ways for Arm, since doubt about the inference shift can pull Arm shares down just as fast.

Arm Moves Apart From Its Sector

Recent results from Arm show the royalty engine at work. In fiscal Q1 2027, the company’s royalty revenue rose 22% to $715 million, while licensing sales climbed 23% to $574 million. Those agreements represent design interest. That interest converts into royalties only as licensees ship silicon, so a demand narrative can lift Arm stock well before it shows up in the financials.

Arm’s operating expenses surged 28% to $1.16 billion in Q1 as research spending ramped up. Heavier costs cut the company’s operating margin to 7% from 11%, a steep drop for an asset-light business. Such a trade-off funds Arm’s AI push at the expense of near-term profits and could weigh on Arm stock whenever sentiment cools off.

At a trailing price-to-earnings (P/E) ratio of 346x, Arm stock is priced for years of strong royalty growth. Arm stock still sits below its 52-week high of $452.70 despite the rebound, a reminder of how wide its trading range has been.

Qualcomm stock and Intel stock are posting only modest gains, which suggests the CPU inference theme is flowing most directly through Arm’s royalty model. Both companies sell finished chips, so any inference benefit gets blended into broader businesses, whereas Arm collects a slice of the silicon shipped across its entire licensee base. That structural difference helps explain why Arm stock can swing far harder than its processor peers on a single narrative.

What the Rebound Means for Arm Investors

Whether Arm stock holds the week’s gain after such a sharp decline remains unresolved. With a beta of 3.89, Arm stock tends to swing hard in both directions, so a reversal could arrive as quickly as the rebound did. On the bull side, a royalty stream tied to CPU inference supports Arm stock, while rising costs and a high multiple anchor the bear case.

Investors adding to their exposure in Arm will want to size their positions modestly given how sharply Arm stock has swung. Staging purchases in smaller batches may help holders manage their risk if Arm stock gives back part of its bounce. Pairing their Arm stake with their broader chip exposure through a diversified semiconductor fund could also cushion the impact of a single-name reversal.

Arm’s next test is whether its royalty growth speeds up enough to justify the inference narrative. Steady gains in royalty revenue could support the rebound, while another quarter of margin pressure might revive the valuation concerns that have recently weighed on Arm stock. Until the financials catch up, holders of Arm may want to size their allocation with that volatility in mind.

Contact [email protected] for any questions or corrections.